Rocca J, Manin S, Hulin A, Aissat A, Verbecq-Morlot W, Pruliere-Escabasse V
Br J Pharmacol. 2016; 173(11):1728-41.
PMID: 26894321
PMC: 4867744.
DOI: 10.1111/bph.13464.
Ritschel W
Pharm Res. 2013; 3(3):173-7.
PMID: 24271525
DOI: 10.1023/A:1016370209604.
Zhang Y, Zhang J, Wang L, Quealy E, Gary B, Reynolds R
Cancer Prev Res (Phila). 2010; 3(7):885-95.
PMID: 20587701
PMC: 4990820.
DOI: 10.1158/1940-6207.CAPR-09-0273.
Davies N, Takemoto J, Brocks D, Yanez J
Clin Pharmacokinet. 2010; 49(6):351-77.
PMID: 20481648
DOI: 10.2165/11319320-000000000-00000.
Lee J, Paine M, Brouwer K
J Pharmacol Exp Ther. 2010; 334(2):410-8.
PMID: 20430841
PMC: 2913772.
DOI: 10.1124/jpet.110.165852.
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
Piazza G, Keeton A, Tinsley H, Gary B, Whitt J, Mathew B
Cancer Prev Res (Phila). 2009; 2(6):572-80.
PMID: 19470791
PMC: 3227417.
DOI: 10.1158/1940-6207.CAPR-09-0001.
Clinical pharmacokinetics of sulindac. A dynamic old drug.
Davies N, Watson M
Clin Pharmacokinet. 1997; 32(6):437-59.
PMID: 9195115
DOI: 10.2165/00003088-199732060-00002.
Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.
Teicher B, Korbut T, Menon K, Holden S, Ara G
Cancer Chemother Pharmacol. 1994; 33(6):515-22.
PMID: 8137463
DOI: 10.1007/BF00686511.
A liner mode of reversible metabolism and its application to bioavailability assessment.
Hwang S, Kwan K, Albert K
J Pharmacokinet Biopharm. 1981; 9(6):693-709.
PMID: 7341755
DOI: 10.1007/BF01070901.
The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.
Woodhouse K, Wynne H
Clin Pharmacokinet. 1987; 12(2):111-22.
PMID: 3549104
DOI: 10.2165/00003088-198712020-00002.
Prodrugs.
Waller D, George C
Br J Clin Pharmacol. 1989; 28(5):497-507.
PMID: 2686738
PMC: 1380009.
DOI: 10.1111/j.1365-2125.1989.tb03535.x.
Prodrugs for the improvement of drug absorption via different routes of administration.
Balant L, Doelker E, Buri P
Eur J Drug Metab Pharmacokinet. 1990; 15(2):143-53.
PMID: 2200683
DOI: 10.1007/BF03190197.
Validation of a column-switching high-performance liquid chromatographic (HPLC) method for determination of ML-1035 and its five metabolites in plasma.
Kuo B, Poole J, Hwang K
Pharm Res. 1992; 9(1):119-25.
PMID: 1589396
DOI: 10.1023/a:1018948314823.
